Innovatis
德國Roche Innovatis AG www.innovatis.com www.roche.com.cn www.roche.com
Innovatis AG 成立于1998年，開發出了世界上第一臺基于臺盼藍染色法的全自動細胞分析儀Cedex，一經推出后很快獲得了世界上眾多著名制藥和生物研究機構認可選用。通過近10年的發展，Innovatis已經成長為世界領先的細胞分析技術公司，為全球用戶提供生物制藥研發和生產過程分析中細胞分析的解決方案。
2009羅氏宣布以1500萬歐元收購德國Innovatis公司
Founded in 1995, innovatis AG ranks among the leading suppliers of systems solutions for process analytics in biotechnology. With the development of the CEDEX automated cell analyzer, innovatis AG early on recognized the market requirements of the future and revolutionized the manual cell counting process previously established in the market. The Cedex, based on an image recognition measurement procedure using the Trypan blue method to determine viability, is now internationally recognized as the "Gold Standard" for cell counting in both biotechnology and R&D within the pharmaceutical industry.
Innovatis continues to make strategic market adjustments through the constant expansion of their product portfolio. With three main locations in Germany, the U.S.A. and Asia, as well as more than 20 sales partners world-wide, innovatis guarantees the necessary close proximity to customers and, thus, short response times in a cost-concious market.
Schärfe System GmbH has, since 1987, likewise developed and sold system technology recognized as a standard for quality control in cell biology. At present, these systems have strengthened their application particularly within the area of basic research. The products available under the brand name of CASY offer a complete line of equipment in themselves: from electronic cell counters/size determiners to cell analyzers that conform to GMP/21 CFR 11 standards with integrated workstations for complete cell culture control and documentation. Consumables, accessories and user software, according to individual requirements, also guarantee optimal results and security for the customer.
From December 1, 2006, the activities of both brands will be managed under the roof of innovatis AG. The Ventizz Capital Advisor Partners AG, for many years investors in innovatis AG, will support this process with a further increases in capital. Reinhard Loechner, Ventizz partner: "With this strategic merger, innovatis AG will become the strong and reliable partner for cell culture analysis".
